UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.59B |
| 2 |
AGN
Allergan plc
AGN
|
+$763M |
| 3 |
Boeing
BA
|
+$639M |
| 4 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$542M |
| 5 |
Apple
AAPL
|
+$402M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$377M |
| 2 |
Ecolab
ECL
|
+$332M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$315M |
| 4 |
iShares US Treasury Bond ETF
GOVT
|
+$306M |
| 5 |
CELG
Celgene Corp
CELG
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.74% |
| 2 | Financials | 7.41% |
| 3 | Healthcare | 6.49% |
| 4 | Consumer Discretionary | 5.87% |
| 5 | Industrials | 5.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4076
Patrick Industries
PATK
$2.95B
| $663K | ﹤0.01% |
20,219
-38,608
| -66% | -$1.21M |
|
4077
Alphatec Holdings
ATEC
$1.44B
| $661K | ﹤0.01% |
145,733
+3,684
| +3% | +$13.7K |
|
4078
iShares Russell Top 200 ETF
IWL
$2.28B
| $658K | ﹤0.01% |
9,678
+60
| +0.6% | +$4.01K |
|
4079
Pathward Financial
CASH
$1.83B
| $657K | ﹤0.01% |
23,406
+19,861
| +560% | +$505K |
|
4080
Smith & Nephew
SNN
$12.6B
| $657K | ﹤0.01% |
15,104
-1,858
| -11% | -$76.9K |
|
4081
WesBanco
WSBC
$4B
| $657K | ﹤0.01% |
17,028
+9,196
| +117% | +$354K |
|
|
CBIO
4082
Crescent Biopharma
CBIO
$626M
| $656K | ﹤0.01% |
551
-189
| -26% | -$226K |
|
4083
Kinross Gold
KGC
$32.8B
| $654K | ﹤0.01% |
168,701
+16,938
| +11% | +$57.1K |
|
4084
WisdomTree Emerging Markets Corporate Bond Fund
EMCB
$98.8M
| $653K | ﹤0.01% |
8,998
-5,437
| -38% | -$389K |
|
4085
Old National Bancorp
ONB
$10.2B
| $651K | ﹤0.01% |
39,203
-6,410
| -14% | -$107K |
|
4086
NACCO Industries
NC
$320M
| $650K | ﹤0.01% |
12,515
+292
| +2% | +$13.6K |
|
4087
First Bancorp
FNLC
$399M
| $648K | ﹤0.01% |
24,117
-74
| -0.3% | -$1.91K |
|
4088
John Wiley & Sons Class B
WLYB
$2.73B
| $647K | ﹤0.01% |
14,096
+10,375
| +279% | +$471K |
|
|
ESV
4089
DELISTED
Ensco Rowan plc
ESV
| $647K | ﹤0.01% |
75,898
+29,141
| +62% | +$337K |
|
|
EMF
4090
Templeton Emerging Markets Fund
EMF
$326M
| $646K | ﹤0.01% |
42,793
-9,788
| -19% | -$146K |
|
|
FFIC
4091
DELISTED
Flushing Financial
FFIC
| $646K | ﹤0.01% |
29,140
+2,222
| +8% | +$49K |
|
4092
CALL
PTC
PTC
$16B
| $646K | ﹤0.01% |
+7,200
| New | +$645K |
|
4093
PUT
Boston Properties
BXP
$11.1B
| $645K | ﹤0.01% |
+5,000
| New | +$672K |
|
4094
iShares MSCI Peru and Global Exposure ETF
EPU
$567M
| $645K | ﹤0.01% |
17,434
-6,317
| -27% | -$234K |
|
4095
Invesco S&P MidCap 400 Pure Value ETF
RFV
$336M
| $644K | ﹤0.01% |
9,603
-1,574
| -14% | -$104K |
|
|
MSGN
4096
DELISTED
MSG Networks Inc.
MSGN
| $644K | ﹤0.01% |
31,074
+14,485
| +87% | +$318K |
|
4097
United Natural Foods
UNFI
$2.85B
| $643K | ﹤0.01% |
71,670
+50,317
| +236% | +$579K |
|
|
EGLE
4098
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $643K | ﹤0.01% |
17,532
+1,271
| +8% | +$45K |
|
4099
Santander
BSBR
$43.5B
| $641K | ﹤0.01% |
56,380
-516
| -0.9% | -$5.61K |
|
4100
Voyager Therapeutics
VYGR
$198M
| $640K | ﹤0.01% |
23,492
+19,763
| +530% | +$452K |
|
Similar funds
UBS Group's Q2 2019 Portfolio in Review
As of Q2 2019, UBS Group held 8,581 positions worth $260B, up 7.3% from $242B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group deployed $9.95B of net new capital in Q2 2019, opening 809 new positions and adding to 3,918 existing holdings. Its largest new stake was Dow Inc: 4,472,376 shares worth $221M.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $377M trimmed.
- UBS Group's largest Q2 2019 buy was Dow Inc: 4,472,376 shares worth $221M.
- UBS Group added most to UBS Group in Q2 2019, an estimated $1.59B increase.
- UBS Group's biggest Q2 2019 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $377M.
- UBS Group fully exited Bemis in Q2 2019, selling an estimated $102M.
- UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q2 2019.
- UBS Group opened 809 new positions and closed 626 in Q2 2019.
- UBS Group's portfolio value rose 7.3% quarter-over-quarter to $260B.
Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.